IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), the
world's leading temperature-controlled logistics company dedicated
to the life sciences industry, today announced that the Company
will report financial results for the third quarter ended
September 30, 2019 on Thursday, November 7, 2019 after U.S. markets
In addition to the earnings release, a document titled "Cryoport
Third Quarter 2019 in Review", which will provide a review of
Cryoport's recent financial and operational performance and a
general business update, will be issued by management at 4:05 pm ET
on Thursday, November 7, 2019. The
document is designed to be read by investors before the questions
and answers conference call and can be accessed at
Cryoport management will host a conference call at 5:00 pm ET on November 7,
2019. The conference call will be in the format of a
questions and answers session and will address any queries
investors have regarding the Company's reported results.
Conference Call Information
+1 (800) 895-3361
(U.S.) or +1 (785) 424-1062 (International)
Request the "Cryoport
section at www.cryoport.com or at this link. Please allow 10
minutes prior to the call to visit this site to download and
install any necessary audio software.
An archive of the question and answer webcast will be available
approximately three hours after completion of the live event and
will be accessible on the Investor Relations section of the
Company's website at www.cryoport.com for a limited time. To
access the replay of the webcast, please follow this link. A
dial-in replay of the call will also be available to those
interested until November 14, 2019.
To access the replay, dial +1 (844) 512-2921 (United States) or +1 (412) 317-6671
(International) and enter replay pin number: 136824.
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is the world's premier
provider of temperature-controlled supply chain solutions for the
life sciences industry, serving the Biopharma, Human
Reproductive, and Animal Health markets. Our mission is to
support life and health on earth by providing reliable and
comprehensive solutions for the life sciences through our advanced
technologies, Global Supply Chain Network and dedicated scientists,
technicians and supporting team of professionals. Through
purpose-built proprietary packaging; information technology; smart,
sustainable cold chain logistics; and biostorage/biobanking
services, Cryoport helps its customers advance life sciences
research, support life-saving advanced therapies and deliver
vaccines, protein producing materials, and IVF treatments in over
100 countries around the world. For more information, visit
www.cryoport.com or follow @cryoport on Twitter
at www.twitter.com/cryoport for live updates.
Forward Looking Statements
Statements in this news release which are not purely
historical, including statements regarding Cryoport, Inc.'s
intentions, hopes, beliefs, expectations, representations,
projections, plans or predictions of the future are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. It is important to note that the Company's
actual results could differ materially from those in any such
forward-looking statements. Factors that could cause actual results
to differ materially include, but are not limited to, risks and
uncertainties associated with the effect of changing economic
conditions, trends in the products markets, variations in the
Company's cash flow, market acceptance risks, and technical
development risks. The Company's business could be affected by a
number of other factors, including the risk factors listed from
time to time in the Company's SEC reports including, but not
limited to, the Company's 10-K for the year ended December 31, 2018 filed with the SEC. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this press release.
Cryoport, Inc. disclaims any obligation, and does not undertake to
update or revise any forward-looking statements in this press
View original content to download
SOURCE Cryoport, Inc.